Mutation-Derived Tumor Antigens: Novel Targets in Cancer Immunotherapy.

Mutation-Derived Tumor Antigens: Novel Targets in Cancer Immunotherapy. Oncology (Williston Park). 2015 12; 29(12):970-2, 974-5.

View in: PubMed